Suchergebnisse - "Held, Gerhard"

PubPharm (4)

1

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) : a randomised, phase 3, non-inferiority trial

enthalten in: Lancet (London, England) | 2019

von Poeschel, V. | Held, G. | Ziepert, M. | +43

CommentIn: Lancet. 2020 Dec 21;394(10216):2208-2209. - PMID 31868615

2

Optimization of rituximab for the treatment of DLBCL : increasing the dose for elderly male patients

enthalten in: British journal of haematology | 2017

von Pfreundschuh, M. | Murawski, N. | Zeynalova, S. | +16

3

Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Bittenbring, J. | Neumann, F. | Altmann, B. | +7

4

The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas

enthalten in: Blood | 2014

von Murawski, N. | Held, G. | Ziepert, M. | +12

1
[1]